Elicio Therapeutics, Inc. (ELTX)
1.92
0.00 (0.00%)
USD |
NASDAQ |
Oct 02, 16:00
1.92
0.00 (0.00%)
After-Hours: 20:00
Elicio Therapeutics EPS Diluted (Quarterly) : -0.427 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.427 |
| March 31, 2026 | -0.6492 |
| December 31, 2025 | -0.4336 |
| September 30, 2025 | -0.604 |
| June 30, 2025 | -0.6576 |
| March 31, 2025 | -0.8655 |
| December 31, 2024 | -1.270 |
| September 30, 2024 | -1.387 |
| June 30, 2024 | -0.6406 |
| March 31, 2024 | -1.151 |
| December 31, 2023 | -0.9318 |
| September 30, 2023 | -1.272 |
| June 30, 2023 | -2.438 |
| March 31, 2023 | -8.277 |
| Date | Value |
|---|---|
| December 31, 2022 | -207.66 |
| September 30, 2022 | -226.70 |
| June 30, 2022 | -232.03 |
| March 31, 2022 | -4.753 |
| December 31, 2021 | 4.970 |
| September 30, 2021 | -5.265 |
| June 30, 2021 | -5.754 |
| March 31, 2021 | -15.65 |
| December 31, 2020 | -9.793 |
| September 30, 2020 | -5.993 |
| June 30, 2020 | -6.899 |
| March 31, 2020 | -4.484 |
| December 31, 2019 | -5.432 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | -0.0146 |
| Amgen, Inc. | 4.366 |
| BioCryst Pharmaceuticals, Inc. | 0.2957 |
| Imunon, Inc. | -0.5412 |
| Curis, Inc. | -4.017 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.217M |
| Total Expenses (Quarterly) | 8.217M |
| Enterprise Value | 32.72M |
| Earnings Yield | -110.1% |
| Normalized Earnings Yield | -111.46 |